eMedicine Specialties > Emergency Medicine > Toxicology

Plant Poisoning, Resins

Author: Hagop A Isnar, MD, FACEP, Associate Medical Director, Consulting Staff, Department of Emergency Medicine, Auburn Memorial Hospital
Coauthor(s): Charles McKay, MD, Chief, Toxicology Section, Department of Traumatology and Emergency Medicine, Hartford Hospital
Contributor Information and Disclosures

Updated: Mar 2, 2009

Introduction

Background

Plants have evolved highly complex systems of defense against most of their natural enemies (eg, insects, animals). At the very least, these defenses make many plants unpalatable; however, some can be fatal to the inexperienced forager.

Throughout human history, plants have played pivotal roles as medicines and poisons. Our medical predecessors may not have known the exact mechanisms involved, but they did recognize various plants as instrumental for medical treatment and as instruments of murder. With current technology, we finally are able to peer into plants and see their vast arsenal of chemicals, including glycosides, alkaloids, oxalates, and resins.

When considering poisoning by plant resin, always be aware of possible co-intoxicants, which may blur the clinical picture. Such co-intoxicants include pharmaceutical and illicit drugs, herbicides, fungicides, insecticides, fertilizers, and artificial plant hormones.

Examples of unintentional toxic plant ingestion include the following:

  • Hikers who mistake poisonous plants for nutritious ones
  • Herbalists who seek natural remedies or natural highs and end up with poisonous concoctions
  • Children who are attracted to brightly colored fruits and leaves of poisonous plants (This group accounts for the most calls to poison centers regarding plant toxicity.)

Pathophysiology

Resins are a diverse group of chemical compounds that share chemical characteristics, such as insolubility in water, solidity at room temperature, and lack of nitrogen group. Resin compounds formed with sugars are called glycoresins; those formed with oils are called oleoresins. Latex is a term used to describe these toxins when found in emulsions (ie, urushiols, which are catechol derivatives) in ducts of plants. They are released and activated when structural damage to the plant occurs.

Frequency

United States

While some individuals ingest toxic plants to attempt suicide, most present to the ED after unintentional toxic plant ingestion.

The 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS) documented 64,236 plant exposures (2.7% of total human exposure).1 This figure is lower than that of 2004 (documented 74,811); however, the overall number of all types of human exposures remain little changed in the past 6 years.2   

Pediatric (children <5 years old) plant exposures in 2006 were noted to be 44,710 or 3.7% of pediatric exposures reported.  

The following is a list of the 25 most commonly reported plant involved in a reported exposure in 2006 NPDS:

  • Spathiphyllum species   - 2,133
  • Euphorbia pulcherrima - 1,615
  • Ilex species - 1,572
  • Philodendron species - 1,514
  • Phytolacca americana - 1,358
  • Toxicodendron radicans - 1,194
  • Schlumbergera bridgesii - 705
  • Ilex opaca - 608
  • Crassula argentea - 604
  • Plants-cardiac glycosides - 583
  • Malus species - 582
  • Taraxacum officinale - 581
  • Pepper mace - 566
  • Epipremnum areum - 566
  • Plants, cyanogenic glycosides - 555
  • Plants, pokeweed - 543
  • Mold - 538
  • Caladium species - 533
  • Nandina domestica - 530
  • Narcissus pseudonarcissus - 474
  • Spinacia oleracea - 467
  • Cactus (unknown type or name) - 460
  • Rosa species - 450
  • Quercus species - 447
  • Hedera helix - 446

Mortality/Morbidity

Five deaths were reported in 2004, which represents 0.007% of all plant exposures.

  • Of all plant exposures reported, only 30% had outcomes reported. Sixty-six percent of the reported outcomes were asymptomatic.
  • Ninety-five percent of all plant exposures reported were unintentional.

Age

Approximately 74% of plant exposures reported to poison centers in 2004 involved children younger than 6 years.

Clinical

History

Most plants involved in exposures reported to poison control centers are identified. However, plants often remain unidentified when patients come to the ED because of concern regarding plant ingestion or symptoms following plant ingestion or exposure.

Because toxic principles of plants may vary greatly by season and geography, systematic evaluation is invaluable for determining the etiology of the patient's symptoms and identifying the potential plant toxin. Generally, this is the case when describing circumstances surrounding the toxicity to the poison center or consulting toxicologist over the telephone.

Emergency physicians must obtain accurate history to determine extent of exposure and subsequent risk of disease. The following items may provide important information:

  • Name of plant (note that common names vary considerably by region)
  • Actual plant (if available, allows for detailed description of features)
  • Amount ingested or exposed
  • Duration of time since exposure
  • Initial symptoms and time between exposure and symptom onset
  • Past medical history, current medication, and allergies (These may alter host response and risk.)

Physical

A thorough examination focusing on existence or development of toxidromes (eg, anticholinergic syndromes, nicotinic syndromes) may be helpful in identifying the general class of toxin(s). It is very important to repeat this evaluation over time (generally several hours) to follow the evolution of symptoms and response to treatment.

  • Many plants cause nonspecific gastrointestinal upset. Possible poison hemlock ingestion is suggested when gastrointestinal upset is accompanied by early onset of increased secretions followed by nicotinic syndromes such as respiratory difficulty, altered mental status, and possibly seizures (see Media file 1).
  • Plant ingestion alone is unlikely to cause isolated altered mental status.
  • Physicians must always consider other causes of acute altered mental status, such as hypoglycemia, co-ingestants, concomitant trauma, or infection.
Hemlock. Photo by Cornell University Poisonous Pl...

Hemlock. Photo by Cornell University Poisonous Plants Informational Database.

Hemlock. Photo by Cornell University Poisonous Pl...

Hemlock. Photo by Cornell University Poisonous Plants Informational Database.


More on Plant Poisoning, Resins

Overview: Plant Poisoning, Resins
Differential Diagnoses & Workup: Plant Poisoning, Resins
Treatment & Medication: Plant Poisoning, Resins
Follow-up: Plant Poisoning, Resins
Multimedia: Plant Poisoning, Resins
References

References

  1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green J, Rumack BH, Heard SE. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol (Phila). Dec 2007;45(8):815-917. [Medline].

  2. Watson WA, Litovitz TL, Rodgers GC. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2005;23(5):589-666. [Medline].

  3. Arena J. Plants That Poison. Emerg Med. Jun 15 1989;20-64.

  4. Braitberg G, et al. Toxic plant ingestions. In: Wilderness Medicine. 1995:862-89.

  5. Brodell RT, Williams L. Taking the itch out of poison ivy. Are you prescribing the right medication?. Postgrad Med. Jul 1999;106(1):69-70. [Medline].

  6. Brook I, Frazier EH, Yeager JK. Microbiology of infected poison ivy dermatitis. Br J Dermatol. May 2000;142(5):943-6. [Medline].

  7. DiPalma JR. Poisonous plants. Am Fam Physician. Apr 1984;29(4):252-4. [Medline].

  8. Evans FJ, Schmidt RJ. Plants and plant products that induce contact dermatitis. Planta Med. Apr 1980;38(4):289-316. [Medline].

  9. Geehr E. Common toxic plant ingestions. Emerg Med Clin North Am. Aug 1984;2(3):553-62. [Medline].

  10. Guin JD. Treatment of toxicodendron dermatitis (poison ivy and poison oak). Skin Therapy Lett. Apr 2001;6(7):3-5. [Medline].

  11. Hardin JW, Arena J. Human Poisonings from Native and Cultivated Plants. 1974:23, 93, 100, 107.

  12. Kunkel DB, Spoerke DG. Evaluating exposures to plants. Emerg Med Clin North Am. Feb 1984;2(1):133-44. [Medline].

  13. Lampe KF, McCann MA. AMA Handbook of Poisonous and Injurious Plants. 1985:56, 68, 115.

  14. Lee NP, Arriola ER. Poison ivy, oak, and sumac dermatitis. West J Med. Nov-Dec 1999;171(5-6):354-5. [Medline].

  15. Litovitz TL, Klein-Schwartz W, Caravati EM, et al. 1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 1999;17(5):435-87. [Medline].

  16. Litovitz TL, Smilkstein M, Felberg L, et al. 1996 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 1997;15(5):447-500. [Medline].

  17. McGovern TW, LaWarre SR, Brunette C. Is it, or isn't it? Poison ivy look-a-likes. Am J Contact Dermat. Jun 2000;11(2):104-10. [Medline].

  18. McKenzie RA, ALIA. Plant poisoning? Which plant?!. Aust Vet J. Jun 1993;70(6):201-2. [Medline].

  19. Patterson SE, Williams JV, Marks JG Jr. Prevention of sodium lauryl sulfate irritant contact dermatitis by Pro- Q aerosol foam skin protectant. J Am Acad Dermatol. May 1999;40(5 Pt 1):783-5. [Medline].

  20. Rondeau ES, Everson GW, Savage W, Rondeau JH. Plant nurseries: a reliable resource for plant identification?. Vet Hum Toxicol. Dec 1992;34(6):544-6. [Medline].

  21. Tilton BR, Ryan ME, Edson LY, Martyak GG. Plant ingestions in children. Pa Med. May 1985;88(5):45-9. [Medline].

Further Reading

Keywords

plant poisoning resins, resins, plant resins, poison ivy, poison oak, poison sumac, contact dermatitis, glycoresins, oleoresins, urushiols, poisonous plants, poisonous plant exposures, plant toxin, Toxicodendron species, Cicuta maculata, water hemlock, cicutoxin, chinaberry, Melia azedarach, tetranortriterpene, daphne, daphnetoxin, toxic plant ingestion, resin skin exposure

Contributor Information and Disclosures

Author

Hagop A Isnar, MD, FACEP, Associate Medical Director, Consulting Staff, Department of Emergency Medicine, Auburn Memorial Hospital
Hagop A Isnar, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Charles McKay, MD, Chief, Toxicology Section, Department of Traumatology and Emergency Medicine, Hartford Hospital
Charles McKay, MD is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, and American College of Medical Toxicology
Disclosure: Nothing to disclose.

Medical Editor

Miguel C Fernandez, MD, FAAEM, FACEP, FACMT, Associate Clinical Professor; Medical and Managing Director, South Texas Poison Center, Department of Surgery/Emergency Medicine and Toxicology, University of Texas Health Science Center at San Antonio
Miguel C Fernandez, MD, FAAEM, FACEP, FACMT is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Medical Toxicology, Society for Academic Emergency Medicine, and Texas Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

John T VanDeVoort, PharmD, Regional Director of Pharmacy, Sacred Heart & St. Joseph's Hospitals
John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists
Disclosure: Nothing to disclose.

Managing Editor

Michael Hodgman, MD, Assistant Clinical Professor of Medicine, Department of Emergency Medicine, Bassett Healthcare
Michael Hodgman, MD is a member of the following medical societies: American College of Medical Toxicology, American College of Physicians, Medical Society of the State of New York, and Wilderness Medical Society
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD, Assistant Professor, Department of Surgery, Section of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.